SOURCE: iData Research

iData Research

August 11, 2015 14:00 ET

Anti-Adhesion Becomes Fastest Growing Wound and Tissue Management Market in Europe Led by Baxter and Ethicon

Over the Forecast Period, the Anti-Adhesion Market Is Expected to Have the Highest Growth Rate Among All the Segments of the European Wound and Tissue Management Market; This Segment Will Increase Faster Than All the Other Markets Due to Current Low Adoption

VANCOUVER, BC--(Marketwired - August 11, 2015) - According to a new report on 15 European markets for wound care and tissue management by iData Research (, Baxter is the leading competitor in the European anti-adhesion market in 2014. They are responsible for the Adept® Adhesion Reduction Solution product, which is one of the very few liquid and cost-effective products on the market compared to other competitors.

Ethicon Gynecare, a Johnson & Johnson company, is a close second in the market with over a quarter of the market share. They are responsible for the GYNECARE INTERCEED® Absorbable Adhesion Barrier, a film-based product made of oxidized regenerated cellulose and indicated for use in open (laparotomy) gynecological and pelvic surgeries. Their competitor Genzyme produces a similar product by the name of Seprafilm® Adhesion Barrier. In order to compete effectively with Genzyme's Seprafilm®, Ethicon set the price of INTERCEED® below that of Seprafilm®. As a result, over the forecast period, Ethicon is expected to increase its market share in this segment, thanks to their vast portfolio of complementary products in biosurgery and wound closure that enable them to bundle their products in order to offer volume discounts for prospective customers.

Anti-adhesion products are used for preventing the scarring or adhesion of internal tissue after surgical procedures. They are mainly used in gynecological procedures, which accounted for approximately 54% of the total anti-adhesion market in 2014. Surgical adhesions are fibrous bands that form between tissues and organs, often as a result of injury during surgery. Growth in this market will be driven by its ability to form an adhesion in any type of surgery, including abdominal, orthopedic, cardiac and neurological procedures.

"The use of these products is highly dependent on surgeon preference," explains Dr. Kamran Zamanian, CEO of iData. "Though usage varies from country to country in Europe, there is a general trend within each country for younger surgeons to use these products versus older established surgeons, who are more resistant to altering their practice habits."

Often surgeons are more concerned with treating their patient and finishing the operation successfully than preventing adhesions and thus the market penetration remains low. However, the cost of treating adhesions that cause symptoms such as chronic pain, infertility and small bowel obstruction through follow-up surgeries is very expensive. Therefore, endorsements from related medical associations specializing in gynecological and abdominal surgeries would be a big driver for this market. Competitors are investing time to educate surgeons on the benefits of anti-adhesion products and attempting to gain this recommendation from these physicians.

For Further Information
More on the anti-adhesion market in Europe can be found in the report published by iData entitled European Markets for Wound and Tissue Management. This report wound closure, antimicrobial dressing, interactive dressing, hemostats, tissue sealants, anti-adhesives, negative pressure wound therapy, and bandages.

The iData series on the market for wound care and tissue management devices covers the U.S., Brazil, China, India, Japan and 15 countries in Europe encompassing Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment.

To find out more about European wound and tissue market data or procedure data, register online or email us at for a European Markets for Wound and Tissue Management report brochure and synopsis.

About iData Research
iData Research ( is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology, and more.

Contact Information